Endothelial cell expression of haemoglobin α regulates nitric oxide signalling.
Adam C Straub, Alexander W Lohman, Marie Billaud...
https://pubmed.ncbi.nlm.nih.gov/23123858/Actively Recruiting
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-08-07
300
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying blood disorders such as sickle cell disease and malaria to better understand how alpha and beta globin variants affect these conditions and other diseases involving inflammation or vascular problems. This research involves collecting biological samples from both people with blood disorders and healthy volunteers to support laboratory and clinical studies. The goal is to learn more about the role of globin variants in normal human physiology and disease development. Participants will provide various biological samples over a period of up to 5 years. Samples may include saliva, urine, blood, blood waste products, fat tissue, and lung mucus and cells obtained via bronchoscopy. Some procedures involve sedation and minor tissue collection, while others involve simple collection methods like spitting or urinating into a cup. Participants can choose which samples to provide and are not required to give all types. Throughout the study, participants will undergo initial screening with medical history, physical exams, blood and urine tests, and may have chest x-rays and heart tests if undergoing bronchoscopy. Researchers will collect and store the biological samples for ongoing research. The study will monitor safety and participant health over several years, gathering information to advance understanding of blood disorders and related conditions.
CONDITIONS
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
M
Mary J Jackson, R.N.
H
Hans C Ackerman, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Adam C Straub, Alexander W Lohman, Marie Billaud...
https://pubmed.ncbi.nlm.nih.gov/23123858/Frédéric B Piel, David J Weatherall
https://pubmed.ncbi.nlm.nih.gov/25390741/S H Embury, A M Dozy, J Miller...
https://pubmed.ncbi.nlm.nih.gov/6172710/National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor